glp-1 drugs and parkinson's disease Glucagon-like peptide-1 medicines in neurological psychiatric disorders: Cell Reports Medicine A Big Week for GLP-1
Description
No, GLP-1 receptor agonists are not FDA-approved for joint pain treatment
Eventually, these changes lead to increased peripheral resistance, left ventricular hypertrophy and atrial dilation
Led by Dr
doi: 10.1053/j.gastro.2013.02.007
The answer is probably both direct and indirect, Habegger said
Iype J, Fux M
